| Recruiting | Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults NCT07025434 | Dominican University New York | N/A |
| Completed | A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjec NCT06929052 | Kashiv BioSciences, LLC | Phase 1 |
| Completed | A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China NCT06701149 | Simcere Pharmaceutical Co., Ltd | Phase 1 |
| Recruiting | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects NCT06635226 | IlDong Pharmaceutical Co Ltd | Phase 1 |
| Completed | A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects NCT06857799 | Peking University First Hospital | Phase 1 |
| Completed | Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects NCT06063291 | IlDong Pharmaceutical Co Ltd | Phase 1 |
| Completed | Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects NCT06107205 | Shanghai Auzone Biological Technology Co., Ltd. | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects NCT05917782 | Connect Biopharm LLC | Phase 1 |
| Completed | An Open-label DDI Study of Omaveloxolone in Healthy Subjects NCT05909644 | Biogen | Phase 1 |
| Completed | A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Par NCT05632211 | Alvotech Swiss AG | Phase 1 |
| Unknown | A Trial of CRB4101 in Healthy Subjects NCT05641181 | China Resources Biopharmaceutical Co., Ltd | Phase 1 |
| Unknown | Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects NCT05334043 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | A Phase I Pharmacokinetics Study for KT07 Capsule NCT05223660 | Yiling Pharmaceutical Inc. | Phase 1 |
| Completed | A Study On Human Mass Balance And Biotransformation NCT05040113 | Connect Biopharm LLC | Phase 1 |
| Completed | Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets NCT05002231 | Fulcrum Therapeutics | Phase 1 |
| Completed | A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses) NCT04979572 | Taisho Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults NCT04811469 | Connect Biopharma Australia Pty Ltd | Phase 1 |
| Completed | Safety, Tolerability and Pharmacokinetics Study of CK-3773274 NCT04783766 | Corxel Pharmaceuticals | Phase 1 |
| Completed | Bioavailability of Curcumin Capsules in Healthy Adult Subjects NCT04972045 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube NCT04776135 | Tanabe Pharma Corporation | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults NCT04629131 | Zhuhai Trinomab Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Safety, Tolerability and Pharmacokinetics of FTX-6058 NCT04586985 | Fulcrum Therapeutics | Phase 1 |
| Completed | A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib NCT04494659 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Gastrointestinal Tolerance Assessment of T2309 NCT04596605 | Laboratoires Thea | N/A |
| Completed | A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers NCT04395053 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects NCT04627129 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers NCT04400123 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects NCT04291846 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Study of TTYP01 in Healthy Adult Subjects NCT04370431 | Shanghai Auzone Biological Technology Co., Ltd. | Phase 1 |
| Completed | Dietary Supplement With and Without a Probiotic NCT04433208 | Prolacta Bioscience | N/A |
| Completed | A Study of NPC-22 in Healthy Adult Males NCT04203862 | Nobelpharma | Phase 1 |
| Completed | A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects NCT04335266 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free NCT03960489 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Completed | A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone NCT04008186 | Biogen | Phase 1 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) NCT05342597 | Tanabe Pharma Corporation | Phase 1 |
| Completed | Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects NCT04521192 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects NCT04493281 | Tanabe Pharma Corporation | Phase 1 |
| Completed | Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects NCT03794180 | I-Mab Biopharma US Limited | Phase 1 |
| Completed | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary R NCT04481789 | Tanabe Pharma Corporation | Phase 1 |
| Completed | A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Co NCT04029090 | Tanabe Pharma Corporation | Phase 1 |
| Completed | Study of Oral Edaravone in Healthy Adult Males NCT04481750 | Tanabe Pharma Corporation | Phase 1 |
| Completed | A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY35 NCT03381547 | Eli Lilly and Company | Phase 1 |
| Completed | A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) NCT03267732 | Eli Lilly and Company | Phase 1 |
| Completed | Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers NCT02691702 | Biogen | Phase 1 |
| Unknown | A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of NCT02444507 | isRed Pharma & Biotech Research Corporation | Phase 4 |
| Completed | Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers NCT02168595 | GlycoMimetics Incorporated | Phase 1 |
| Completed | A Phase 1 Study to Assess Pharmacokinetics of Metadoxine (MG01CI) 1400 mg, Administered to Healthy Volunteers NCT01933997 | Alcobra Ltd. | Phase 1 |
| Completed | ONO-2952 Single-dose PET Study in Healthy Adult Subjects NCT01613703 | Ono Pharma USA Inc | Phase 1 |
| Completed | Single Dose Escalation Study of ONO-9054 in Healthy Volunteers NCT01508988 | Ono Pharma USA Inc | Phase 1 |
| Completed | A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers NCT01537172 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers NCT01433835 | Microbiotix, Inc. | Phase 1 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects NCT01405651 | Ono Pharma USA Inc | Phase 1 |
| Terminated | A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers NCT01379586 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subj NCT01364441 | Ono Pharma USA Inc | Phase 1 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult NCT01297582 | Ono Pharma USA Inc | Phase 1 |
| Completed | Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult Subjects NCT01366326 | Bausch Health Americas, Inc. | Phase 1 |
| Completed | ONO-7746 Study in Healthy Adult Subject NCT01106664 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects NCT01376063 | Kyntra Bio | Phase 1 |
| Completed | ONO-7746 Study in Healthy Adult Subjects NCT00956371 | Ono Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Prebiotic Effect of a Jelly Containing Short Chain Fructo-Oligosaccharides and Sideritis Euboea Extract NCT00971113 | Harokopio University | N/A |
| Completed | Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX NCT01366378 | Bausch Health Americas, Inc. | Phase 1 |